News
UK Regulator Cites CluePoints Solutions in Updated Guidance
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’...
News
Studying Clinical Decision Support Systems In Mental Illness
Researchers, in a new study, showed that using a clinical decision support system that stimulates doctors to provide personalised informational handouts about a patient's cardiovascular risk and treatment recommendations can dramatically lower heart disease risk for patients with severe...
News
Researchers Take Steps In Developing Regenerated Bone Tissue
According to an announcement made on February 15, 2022, McGill University researchers adopted the Canadian Light Source (CLS) at the University of Saskatchewan to create a unique approach for manufacturing synthetic bone tissue. The discovery comes after more than 30...
News
Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines
Novo Nordisk announced the expansion of its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital (BWH).
Since 2015, scientists from Novo Nordisk and the laboratories of Prof. Giovanni...
News
EC approves Boehringer-Lilly’s Jardiance for chronic heart failure
The European Commission (EC) has granted marketing authorisation to Boehringer Ingelheim and Eli Lilly and Company’s Jardiance (empagliflozin) to treat symptomatic chronic heart failure in adult patients.
With the latest development, Jardiance became the first treatment to be approved for...
Drug Research
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
Midatech Pharma PLC, a drug delivery technology company, announced an extension of its existing R&D collaboration with Janssen Pharmaceutica NV (Janssen) originally announced on 21 July 2020.
On 17 June 2021 the company announced that, using its Q-Sphera technology, it...
News
Curia Enters Cooperative Agreement with U.S. Government to Expand Sterile Fill-Finish Capability
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced a cooperative agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS) Office of the Assistant Secretary...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read